187527-25-9 Purity
---
If you have any other questions or need other size, please get a quote.
Reference: [1]Current Patent Assignee: SUZHOU LAKESTAR PHARMATECH - CN112625043, 2021, A
Location in patent: Paragraph 0020; 0028; 0030; 0036; 0038
Reference: [1] Bulletin de la Societe Chimique de France, 1925, vol. <4> 37, p. 889
[2] Journal of the Chemical Society, 1937, p. 16,25
[3] Journal of the Chemical Society, 1937, p. 16,25
[4] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 16, p. 541
Reference: [1] Gazzetta Chimica Italiana, 1911, vol. 41 II, p. 769
[2] Gazzetta Chimica Italiana, 1911, vol. 41 II, p. 769
Reference: [1] Chemistry of Heterocyclic Compounds, 2012, vol. 47, # 11, p. 1353 - 1366[2] Khim. Geterotsikl. Soedin., 2011, vol. 47, # 11, p. 1632 - 1648,17
Reference: [1]Hearn, Michael J.; Lucero, Elena R.
[Journal of Heterocyclic Chemistry, 1982, vol. 19, p. 1537 - 1539]
[2]Abdulrahman, Hayman Sardar; Ahmad, Mohd Hafiz; Al-Ani, Lina A.; Hashim, Najihah M.; Hassan Mohammed, Mohamed; Yehye, Wageeh A.
[Journal of Chemistry, 2020, vol. 2020]
[3]Salman, Mohammad; Ray, Suprabhat
[Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1981, vol. 20, # 6, p. 477 - 479]
[4]Drew; Hatt
[Journal of the Chemical Society, 1937, p. 16,25]
[5]Afarinkia, Kamyar; Rees, Charles W.; Cadogan, John I. G.
[Tetrahedron, 1990, vol. 46, # 20, p. 7175 - 7196]
Reference: [1]Journal of the Chemical Society. Perkin transactions I,1991,p. 1344 - 1346
* For details of the synthesis route, please refer to the original source to ensure accuracy.